Answer: Besides causing skin irritations, and sometimes severe allergic reactions in our pets, fleas also are a source
of other diseases for pets and humans.
It also excitingly demonstrates the potential for treatment of a large number
of other diseases for which existing therapies are either unsatisfactory or unavailable.»
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability
of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential
for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost
of accommodating, announced increases in the build rates
of certain aircraft; 6) the effect on aircraft demand and build rates
of changing customer preferences
for business aircraft, including the effect
of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result
of global economic uncertainty or otherwise; 8) the effect
of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution
of key milestones such as the receipt
of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or
other third party approvals
for the consummation
of our announced acquisition
of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our
other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability
of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and
other customers, and the risk
of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production
of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts
of terrorism; 14) any adverse impact on the demand
for air travel or our operations from the outbreak
of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or
other security attacks, information technology failures, or
other disruptions; 16) returns on pension plan assets and the impact
of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price
for our announced acquisition
of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and
other aerostructures suppliers; 19) the effect
of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect
of changes in tax law, such as the effect
of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations
of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect
of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability
of raw materials and purchased components; 23) our ability to recruit and retain a critical mass
of highly - skilled employees and our relationships with the unions representing many
of our employees; 24) spending by the U.S. and
other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate
for our additional capital needs or
for payment
of interest on, and principal
of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness
of any interest rate hedging programs; 28) the effectiveness
of our internal control over financial reporting; 29) the outcome or impact
of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and
other cost savings; 32) our ability to consummate our announced acquisition
of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and
other business disruptions
for ourselves and Asco as a result
of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks
of doing business internationally, including fluctuations in foreign current exchange rates, impositions
of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among
other things.
That means that,
for the first time ever, Americans won't have to get a prescription to receive plain - English medical reports about their chances
of developing
diseases like Alzheimer's, Parkinson's
disease, celiac
disease, and
other disorders based on analyses
of their genetic makeup.
One research project,
for example, focuses on using robots to recognize the facial reactions
of Parkinson's
Disease patients who have lost the ability to convey emotion to
others because
of reduced muscle activity.
Founded in 2011, Innovent has built a portfolio
of 16 potential products
for treating cancer, autoimmune disorders and
other diseases, and seven
of those are in clinical development.
«
For the first time, scientists have attempted to account for numbers of people with biomarkers or other evidence of possible preclinical Alzheimer's disease, but who do not have impairment or Alzheimer's dement
For the first time, scientists have attempted to account
for numbers of people with biomarkers or other evidence of possible preclinical Alzheimer's disease, but who do not have impairment or Alzheimer's dement
for numbers
of people with biomarkers or
other evidence
of possible preclinical Alzheimer's
disease, but who do not have impairment or Alzheimer's dementia.
Other than accidents and suicides, the top 10 leading causes
of death encompass stroke, Alzheimer's, diabetes, the flu and pneumonia, and kidney
disease, according to the Centers for Disease Control
disease, according to the Centers
for Disease Control
Disease Control (CDC).
And much
of the reason its creators felt confident enough to invest all that time, money, and effort — given the small number
of patients who might eventually use the medicine — can be traced to the Orphan Drug Act, a 1983 federal law that gave those who develop meds
for uncommon
diseases longer periods
of marketing exclusivity and
other financial incentives.
But, at least in the venture capital world, funding
for companies focused on tackling heart
disease, respiratory
disease, and
other mass population conditions — i.e., those that afflict millions upon millions
of people — has dropped sharply in the last decade.
Other activities include: producing products that may be recycled at the end
of their lifespan
for material reuse; reducing energy consumption in operations; or even re-engineering distribution methods as a means
of reducing long - distance travel during product delivery, ultimately reducing fossil fuel consumption (and the
disease - causing air pollution that is its byproduct).
But before his arrest, he said he'd use KaloBios as a vehicle to nab another niche drug, this time
for treatment
of the parasitic infection Chagas
disease, and dramatically increase its price to the $ 60,000 to $ 100,000 range after helping it win FDA approval (the drug is approved in
other countries and is provided to patients in the U.S. on a special and selective basis).
«The GUIDES indicators that focus on some overall macroeconomic indicators,» Chisa recommends, plus «a few
other topics that get you a lot
of bang
for the buck: British Colonialism, nations versus states, Dutch
Disease (resource curse), Sovereign Wealth Fund, import substitution, current account balance, fiscal deficit, IMF austerity measures, and the «trilemma»
of free - capital flows, independent monetary policy, and fixed exchange rates.»
In recent years, Levine and
others have used clinical studies to prove that even in healthy people, a chair - based lifestyle sets up the physiological conditions
for the onset
of Type 2 diabetes, cardiovascular
disease, obesity — and ultimately, shorter lifespans.
«A Centers
for Disease Control and Prevention study found that from 1998 to 2008, leafy greens were associated with more incidents
of food poisoning than any
other single food category (though contaminated poultry led to more deaths),» Harrington reports.
Among
others, he's invested in the cervical cancer screening tool MobileODT and Biomeme, which claims to do genetic testing
for certain types
of diseases within an hour.
Sources say the spread
of swollen shoot and
other diseases could become difficult to manage
for the government and cocoa production may become less predictable as a result.
LONDON / ABIDJAN, May 1 (Reuters)- Ivory Coast's move to halt the distribution
of high - yielding seeds and
other advanced tools to cocoa farmers could pave the way
for problems regarding quality, more erratic production and the spread
of diseases, industry sources warn.
About Nohla Therapeutics Nohla Therapeutics is a leading developer
of off - the shelf cell therapies
for the treatment
of cancer and
other critical
diseases.
(
For example, Optiva ads that ran in national consumer magazines claimed that using the competing Braun product wouldn't prevent the growth
of bacteria that might contribute to heart
disease, stroke, low birth weight, and
other life - threatening conditions.)
«Every new person affected by measles in Europe reminds us that unvaccinated children and adults, regardless
of where they live, remain at risk
of catching the
disease and spreading it to
others who may not be able to get vaccinated,» said Dr Zsuzsanna Jakab, the organization's regional director
for Europe.
• Oyster Point Pharmaceuticals Inc., a San Francisco - based developer
of treatments
for dry eye and
other diseases of the ocular surface, raised $ 22 million in Series A funding.
* Ivory Coast's move to halt the distribution
of high - yielding seeds and
other advanced tools to cocoa farmers could pave the way
for lower quality, more erratic output and the spread
of diseases, industry sources warn.
Data from a number
of other studies, including the Nurses» Health Study and the Health Professionals Follow - up Study also report greater risk
of type 2 diabetes, high blood pressure, heart
disease and metabolic syndrome, which is related to diabetes and cardiovascular problems,
for consumers
of artificially sweetened beverages.
Perhaps this will include research and development
of drugs
for other diseases, albeit with fewer researchers, but to date, neither the amount the company will save nor its specific use
of these freed - up resources has been detailed.
The Food and Drug Administration is deliberately preventing the public from getting natural cures
for cancer and
other diseases because
of pressure from drug companies.
By bringing a drug that's been well - established as safe in
other markets to the U.S.
for the first time in order to treat a rare
disease, the company doesn't just control its pricing destiny — it will also receive a coveted «priority review voucher» which it can hawk to another firm
for tens (or even hundreds)
of millions
of dollars.
While some
of the firm's flagship treatments are facing patent expiration, Saunders has been on a quest to snap up a huge number
of biotechs developing drugs
for liver
disease, Alzheimer's, and
other conditions.
Minoryx is a clinical stage biotech company leading the development
of new therapies
for X-linked Adrenoleukodystrophy (X-ALD) and
other inborn errors
of metabolism, a group
of rare
diseases of genetic origin with a high unmet medical need.
While high price tags are common
for rare
disease drugs, Emflaza is part
of a class
of drugs called corticosteroids that are used
for DMD in
other parts
of the world.
He said that many patients use the drug
for far less than a year and that the price was now more in line with those
of other drugs
for rare
diseases.
Contamination from upstream tar sands / oil sands development is causing higher levels
of cancer and
other serious
disease for members
of the Athabasca Chipewyan and...
TORONTO, Mar. 3, 2015 — ChipCare Corporation, a University
of Toronto and MaRS Health start - up commercializing a handheld, blood - testing platform
for HIV and
other infectious and non-communicable
diseases has closed a $ 5.045 million Series A financing to bring its first - generation product to market while further developing the platform's next generation products.
According to a 2017 analysis
of fatal and nonfatal childhood firearm injuries compiled by researchers from the Centers
for Disease Control and Prevention, black children face the highest rates
of firearm mortality — a difference largely driven by black youth being more likely to be shooting victims than children from
other racial groups.
Maastricht, The Netherlands, 1 November 2017 — Cristal Therapeutics, a clinical stage biopharmaceutical company developing targeted nanomedicines
for the treatment
of cancer and
other diseases with high unmet patient need, announced today that it has begun a Phase 1b...
This is hypothesized to happen
for many different reasons, including a decline in the competitiveness
of other economic sectors (caused by appreciation
of the real exchange rate as resource revenues enter an economy, a phenomenon known as Dutch
disease), volatility
of revenues from the natural resource sector due to exposure to global commodity market swings, government mismanagement
of resources, or weak, ineffectual, unstable or corrupt institutions (possibly due to the easily diverted actual or anticipated revenue stream from extractive activities).
Real health care reform would be
for the millions
of «on the dolers» to shut up and take an active part in their own health... a good start... eliminate diabetes, cancer, lung and
other diseases for a good part.
The article concludes: «
For those Christians opposed to elective abortion, however, the issue becomes complicated because
of the laudatory goals
of those trying to help persons suffering from diabetes, Parkinson's, and
other diseases.
The struggle is against a system
of Corporate Power profiting from hunger to pharmaceuticals
for disease and
other forms
of human wants.
We don't have to bring our population under control, but eventually nature will do it
for us by
disease, starvation, or some
other event that will wipe out billions
of people.
Fear, on the
other hand, is a dry nurse
for the child: it has no milk; a bloodless corrector
for the youth: it has no beckoning encouragement; a niggardly
disease for the adult: it has no blessing; a horror
for the aged: when fear has to admit that the long painful time
of schooling did not bring Eternal Blessedness.
The next time you get a cold, a headache, or one
of your children get the measles, mumps, or some
other childhood
disease... make sure you pray
for forgiveness
for your cursing God!
Half are
for various forms
of cancer; the
other half represent a cluster
of rare
diseases, including early - onset Alzheimer's.
In the end, the musical clearly has no time
for lazy, white westerners turning up on the
other side
of the world with a bag full
of Bibles but no practical hope
for the
disease, poverty and violence that dominates many
of these places.
Brian, Well I suppose I do have a fear about what these fantasy beliefs can do to cause trouble all over the world, as if we don't have enough with real problems
of political ills, poverty,
diseases and natural disasters; but mostly I am repelled by so many, like eaglemt and the huge number
of others like him / her, who preach hell - fire and eternal torment
for those who don't regard their unproven beliefs as reality.
I myself will never adopt an understanding that the power to overcome «
disease» or sin or «sickness» or whatever alcoholism is, can be received from, or operated with, «something» or «somebody» or a «power greater than myself» or a «higher power» or a «group» or a light bulb, chair, bulldozer, goddess, doorknob, radiator or any
of the
other «absurd names
for God» (as Rev. Sam Shoemaker, our «cofounder» described them).
It may be shown that by having due regard
for cleanness
of the body and
of clothing one both helps guard against
disease and does honor to
other persons and to oneself.
Testing on the genetic link
for cystic fibrosis, Huntington's
disease, Duchenne's muscular dystrophy and
other diseases indicates that environmental influences, especially the health and habits
of the mother, determine to some extent the form and severity
of an offspring's
disease.
Hence once again with excuses it is even worse than with a virulent
disease,
for no one dies
of a
disease simply because
others have died
of it.
Craig maybe the definition
of teaching men under authority is limited to that particular area within the church.But that does nt stop God from working outside those constraints.Mother Etta and no doubt
other women felt compelled to preach the gospel such as women missionaries.Mother Etta preached the gospel and many were saved people were healed just as in the day
of the disciples it is the same Jesus that saves and delivered from from sin and
disease not the fact that it was a man who spoke behind the altar.Why do you find it hard to see that God can use women just like he uses men to witness
for him.The call to witness
for Christ is
for everyone not just men and not just in a church situation.When we limit God to a narrow view it limits the effectiveness
of the gospel.